Wainberg, Michael
Merico, Daniele
Delong, Andrew
Frey, Brendan J
Article History
Received: 12 October 2017
Accepted: 1 August 2018
First Online: 1 October 2018
Competing interests
: All authors are, or recently were, employees of Deep Genomics, an AI therapeutics company, which is using deep learning to identify the genetic determinants of disease and to develop therapies.